EVAX logoEVAX
Evaxion Biotech

3,419
Loading...
Loading...
Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
46

Frequently Asked Questions

What is Market Cap of Evaxion A/S - ADR?
What is the 52-week high for Evaxion A/S - ADR?
What is the 52-week low for Evaxion A/S - ADR?
What is Evaxion A/S - ADR stock price today?
What was Evaxion A/S - ADR stock price yesterday?
What is the PE ratio of Evaxion A/S - ADR?
What is the Price-to-Book ratio of Evaxion A/S - ADR?
What is the 50-day moving average of Evaxion A/S - ADR?
How many employess does Evaxion A/S - ADR has?

Latest EVAX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.